{"id":933,"date":"2026-10-20T03:32:19","date_gmt":"2026-10-20T01:32:19","guid":{"rendered":"http:\/\/novameds.local\/de\/?post_type=product&#038;p=933"},"modified":"2026-10-20T04:00:54","modified_gmt":"2026-10-20T02:00:54","slug":"catalog-mirabegron-50mg","status":"publish","type":"product","link":"https:\/\/novameds.health\/de\/produkt\/catalog-mirabegron-50mg\/","title":{"rendered":"Mirabegron 50mg"},"content":{"rendered":"<section id=\"composition\" data-nav=\"Zusammensetzung und Produktdetails\">\n<h2>Zusammensetzung und Produktdetails<\/h2>\n<div class=\"nm-catalog-document\">\n<div>\n<h2>\u00dcbersicht<\/h2>\n<div>\n<p>Mirabegron is a selective \u03b23-adrenoceptor (\u03b23-AR) agonist investigated for its effects on \u03b2-adrenergic signaling pathways and receptor-mediated regulation of cellular activity. Experimental studies have examined its interactions with \u03b23-AR-associated cAMP signaling, Gs-protein-coupled signal transduction mechanisms, and downstream regulatory pathways.<\/p>\n<p>Its high selectivity for \u03b23-adrenoceptors relative to \u03b21- and \u03b22-adrenoceptor subtypes makes it a valuable research tool for studies of receptor subtype pharmacology, adrenergic signaling networks, adipocyte-associated signaling mechanisms, thermogenic pathway regulation, and comparative \u03b2-adrenoceptor selectivity.<\/p>\n<p>Research applications include \u03b23-adrenoceptor pharmacology, G-protein-coupled receptor signaling, metabolic pathway investigation, and adrenergic receptor subtype characterization.<\/p>\n<ul>\n<li> <span><b>High Purity<\/b> \u2013 99% Purity Guaranteed<\/span><\/li>\n<li> Independently Lab Tested<\/li>\n<li> Research Grade Quality<\/li>\n<li> For Laboratory Research Use Only<\/li>\n<\/ul><\/div>\n<div>\n<div><span>All SwissChems products are independently third-party tested at a USA-based HPLC-licensed laboratory prior to distribution. Certificates of Analysis (COA) are published on the Independent Test Results page and available at product level. If any independently conducted HPLC test returns a negative result, SwissChems will refund: (1) the cost of the HPLC test, and (2) the full order amount including shipping.<\/span><\/div>\n<div>\n<div><span>Mirabegron 50mg<\/span><span>30caps | 90caps<\/span><\/div>\n<\/div><\/div>\n<\/p><\/div>\n<div>\n<h2>Eigenschaften<\/h2>\n<div class=\"nm-catalog-table\" tabindex=\"0\" role=\"region\" aria-label=\"Product data\">\n<table>\n<tbody>\n<tr>\n<th>Chemical Formula<\/th>\n<td>C21H24N4O2S<\/td>\n<\/tr>\n<tr>\n<th>Synonyms<\/th>\n<td>YM-178, (R)-2-(2-Amino-1,3-thiazol-4-yl)-4&#8242;-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetanilide<\/td>\n<\/tr>\n<tr>\n<th>Molar Mass<\/th>\n<td>396.51 g\/mol<\/td>\n<\/tr>\n<tr>\n<th>CAS Number<\/th>\n<td>223673-61-8<\/td>\n<\/tr>\n<tr>\n<th>PubChem CID<\/th>\n<td>9865528<\/td>\n<\/tr>\n<tr>\n<th>Verf\u00fcgbare Formate<\/th>\n<td>30caps \u00b7 90caps<\/td>\n<\/tr>\n<tr>\n<th>Shelf Life<\/th>\n<td>36 months<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div><\/div>\n<div>\n<h2>Forschung<\/h2>\n<p>\t\t\t\t\t<span>Mirabegron is a selective \u03b23-adrenoceptor (\u03b23-AR) agonist investigated for its effects on \u03b2-adrenergic signaling pathways and Gs-protein-coupled receptor activation. Upon binding to \u03b23-adrenoceptors, mirabegron stimulates adenylyl cyclase activity, increasing intracellular cAMP levels and activating downstream PKA-dependent signaling cascades. Experimental studies have examined its effects on \u03b23-AR-mediated signal transduction, lipolytic pathway regulation, UCP1-associated thermogenic signaling, cellular energy metabolism, and receptor subtype-selective pharmacology. Its high selectivity for \u03b23-adrenoceptors relative to \u03b21- and \u03b22-adrenoceptor subtypes makes it a valuable research tool for investigations of adrenergic receptor signaling, G-protein-coupled receptor pharmacology, thermogenic pathway regulation, metabolic signaling networks, and comparative \u03b2-adrenoceptor subtype characterization.<\/span>\t\t\t\t\t<\/div>\n<div>\n<h2>Laborergebnisse<\/h2>\n<p>Results refer to the tested sample. Check the batch and date in the report.<\/p>\n<div>\n<div>\n<div><\/div>\n<div>\n<div>HPLC Mirabegron (9412)<\/div>\n<div>September 24, 2026<\/div>\n<\/p><\/div>\n<div><a href=\"https:\/\/swisschems.is\/wp-content\/uploads\/2026\/06\/SC-Mirabegron-9412.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Open PDF<\/a><span> \u00b7 <\/span><a href=\"https:\/\/coas.freedomdiagnosticstesting.com\/Swis2609239098.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Laboratory source<\/a><\/div>\n<\/p><\/div>\n<div>\n<div><\/div>\n<div>\n<div>HPLC Mirabegron (3300)<\/div>\n<div>September 24, 2026<\/div>\n<\/p><\/div>\n<div><a href=\"https:\/\/swisschems.is\/wp-content\/uploads\/2026\/06\/Mirabegron-3300.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Open PDF<\/a><span> \u00b7 <\/span><a href=\"https:\/\/coas.freedomdiagnosticstesting.com\/Swis2609239097.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Laboratory source<\/a><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div>\n<h2>FAQ<\/h2>\n<div>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>What is the mechanistic basis for mirabegron&#8217;s research interest in \u03b23-adrenoceptor-mediated thermogenic signaling?<\/span><\/p>\n<\/summary>\n<div>\n<p>\u03b23-adrenoceptor activation stimulates Gs\u03b1-mediated activation of adenylyl cyclase, increasing intracellular cAMP concentrations and downstream PKA signaling. This signaling cascade regulates UCP1-associated pathways, hormone-sensitive lipase (HSL) activation, PGC-1\u03b1-associated transcriptional programs, mitochondrial biogenesis mechanisms, and cellular energy expenditure pathways.<\/p>\n<p>Mirabegron is frequently utilized as a selective \u03b23-AR agonist in studies examining thermogenic signaling networks, receptor-mediated metabolic regulation, and adrenergic control of mitochondrial function.<\/p>\n<\/div>\n<\/details>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>How selective is mirabegron for \u03b23-adrenoceptors relative to other \u03b2-adrenoceptor subtypes?<\/span><\/p>\n<\/summary>\n<div>\n<p>Mirabegron demonstrates substantially greater affinity for \u03b23-adrenoceptors than for \u03b21- or \u03b22-adrenoceptors in receptor-binding and functional signaling assays. This selectivity allows experimental effects observed at appropriate concentrations to be primarily attributed to \u03b23-AR activation.<\/p>\n<p>In studies requiring rigorous receptor-subtype attribution, selective \u03b21- and \u03b22-adrenoceptor antagonists are often incorporated to distinguish \u03b23-mediated signaling from potential off-target adrenergic activity.<\/p>\n<\/div>\n<\/details>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>Why is mirabegron used in \u03b23-adrenoceptor pharmacology research?<\/span><\/p>\n<\/summary>\n<div>\n<p>Mirabegron is one of the most extensively characterized selective \u03b23-adrenoceptor agonists available for experimental investigation. Its well-defined receptor pharmacology, documented activation of \u03b23-AR-dependent signaling pathways, and favorable subtype selectivity make it a valuable research tool for studies of adrenergic receptor signaling, G-protein-coupled receptor pharmacology, cAMP-mediated signal transduction, thermogenic pathway regulation, mitochondrial signaling networks, and comparative \u03b2-adrenoceptor subtype characterization.<\/p>\n<\/div>\n<\/details><\/div>\n<\/p><\/div>\n<div>\n<p>Die Hilfsstoffe der Kapsel sind in den verf\u00fcgbaren Produktunterlagen nicht angegeben.<\/p>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Mirabegron is a selective \u03b23-adrenoceptor (\u03b23-AR) agonist investigated for its effects on \u03b2-adrenergic signaling pathways and receptor-mediated regulation of cellular activity.<\/p>\n<p>Darreichungsform: Mirabegron 50mg.<\/p>\n<p>Gew\u00fcnschte St\u00e4rke und Packungsgr\u00f6\u00dfe ausw\u00e4hlen.<\/p>\n<p class=\"nm-research-disclaimer\">Nur f\u00fcr die Laborforschung. Nicht zur Anwendung bei Menschen oder Tieren.<\/p>\n<p class=\"nm-catalog-image-note\"><small>Mit KI erstellte illustrative Verpackung.<\/small><\/p>\n","protected":false},"featured_media":1052,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[23],"product_tag":[],"nm_classification":[],"class_list":["post-933","product","type-product","status-publish","has-post-thumbnail","product_cat-weight-management-metabolism","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"_links":{"self":[{"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/product\/933","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/comments?post=933"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/media\/1052"}],"wp:attachment":[{"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/media?parent=933"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/product_brand?post=933"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/product_cat?post=933"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/product_tag?post=933"},{"taxonomy":"nm_classification","embeddable":true,"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/nm_classification?post=933"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}